These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 35575284)

  • 21. Associations between fatigue, physical activity, and QoL in patients with myeloproliferative neoplasms.
    Tolstrup Larsen R; Tang LH; Brochmann N; Meulengracht Flachs E; Illemann Christensen A; Hasselbalch HC; Zwisler AD
    Eur J Haematol; 2018 Jun; 100(6):550-559. PubMed ID: 29464777
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Health-related quality of life and its associated variables in Chinese patients with Philadelphia-negative myeloproliferative neoplasms].
    Bao M; Shi DY; Shi HX; Liu XL; Duan MH; Zhuang JL; Du X; Qin L; Hui WH; Liang R; Wang MF; Chen Y; Li DY; Yang W; Tang GS; Zhang WH; Kuang X; Su W; Han YQ; Chen LM; Xu JH; Liu ZG; Huang J; Zhao CT; Tong HY; Hu JD; Chen CY; Chen XQ; Xiao ZJ; Jiang Q
    Zhonghua Xue Ye Xue Za Zhi; 2021 Dec; 42(12):985-992. PubMed ID: 35045668
    [No Abstract]   [Full Text] [Related]  

  • 23. Depressive symptoms and myeloproliferative neoplasms: Understanding the confounding factor in a complex condition.
    Padrnos L; Scherber R; Geyer H; Langlais BT; Dueck AC; Kosiorek HE; Senyak Z; Clark M; Boxer M; Cotter M; Harrison C; Stonnington C; Geda Y; Mesa R
    Cancer Med; 2020 Nov; 9(22):8301-8309. PubMed ID: 32976697
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Traditional Herbal Medicine, Sipjeondaebo-Tang, for Cancer-Related Fatigue: A Randomized, Placebo-Controlled, Preliminary Study.
    Lee JY; Kim EH; Yoon JH; Eo W; Yoon SW
    Integr Cancer Ther; 2021; 20():15347354211040830. PubMed ID: 34672230
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Direct effects of Chinese herbal medicine "hochuekkito" on sperm movement].
    Yamanaka M; Kitamura M; Kishikawa H; Tsuboniwa N; Koga M; Nishimura K; Tsujimura A; Takahara S; Matsumiya K; Okuyama A
    Nihon Hinyokika Gakkai Zasshi; 1998 Jul; 89(7):641-6. PubMed ID: 9739585
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The clinical evaluation of hochuekkito for symptoms of malignant neoplasm patients].
    Kuroda M; Kotake T; Sonoda T; Maekawa M; Okajima E; Okawa T; Ikoma F; Kurita T; Nakamura T; Itatani H
    Hinyokika Kiyo; 1985 Jan; 31(1):173-7. PubMed ID: 2581427
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A Japanese traditional medicine Hochuekkito promotes negative conversion of vancomycin-resistant Enterococci.
    Kohno J; Kawamura T; Kikuchi A; Akaishi T; Takayama S; Ishii T
    Sci Rep; 2021 May; 11(1):11300. PubMed ID: 34050227
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy and safety of Yukgunja-Tang for treating anorexia in patients with cancer: The protocol for a pilot, randomized, controlled trial.
    Kang HJ; Jeong MK; Park SJ; Jun HJ; Yoo HS
    Medicine (Baltimore); 2019 Oct; 98(40):e16950. PubMed ID: 31577697
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Liver injury and hepatic encephalopathy induced by the herbal medicine Hochuekkito].
    Negishi R; Ichikawa T; Tawa Y; Fujimura A; Tanaka S; Tenmoku A; Akazawa K; Kanno M; Sasaki H; Okubo S; Machida N; Fukuda Y; Oi I; Fujino MA
    Nihon Shokakibyo Gakkai Zasshi; 2014 Jun; 111(6):1149-56. PubMed ID: 24898495
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The SIMM study: Survey of integrative medicine in myeloproliferative neoplasms.
    Gowin K; Langlais BT; Kosiorek HE; Dueck A; Millstine D; Huberty J; Eckert R; Mesa RA
    Cancer Med; 2020 Dec; 9(24):9445-9453. PubMed ID: 33140580
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy and safety of Jianpishengsui for chemotherapy-related fatigue in patients with non-small cell lung cancer: study protocol for a randomized placebo-controlled clinical trial.
    Xiao Z; Hu L; Lin J; Lu L; Huang X; Zhu X; Teo C; Lin L
    Trials; 2020 Jan; 21(1):94. PubMed ID: 31948475
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Myeloproliferative Neoplasm Symptom Assessment Form (MPN-SAF): international prospective validation and reliability trial in 402 patients.
    Scherber R; Dueck AC; Johansson P; Barbui T; Barosi G; Vannucchi AM; Passamonti F; Andreasson B; Ferarri ML; Rambaldi A; Samuelsson J; Birgegard G; Tefferi A; Harrison CN; Radia D; Mesa RA
    Blood; 2011 Jul; 118(2):401-8. PubMed ID: 21536863
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Myeloproliferative neoplasms treated with hydroxyurea, pegylated interferon alpha-2A or ruxolitinib: clinicohematologic responses, quality-of-life changes and safety in the real-world setting.
    Gill H; Leung GMK; Yim R; Lee P; Pang HH; Ip HW; Leung RYY; Li J; Panagiotou G; Ma ESK; Kwong YL
    Hematology; 2020 Dec; 25(1):247-257. PubMed ID: 32567517
    [No Abstract]   [Full Text] [Related]  

  • 34. The burden of fatigue and quality of life in myeloproliferative disorders (MPDs): an international Internet-based survey of 1179 MPD patients.
    Mesa RA; Niblack J; Wadleigh M; Verstovsek S; Camoriano J; Barnes S; Tan AD; Atherton PJ; Sloan JA; Tefferi A
    Cancer; 2007 Jan; 109(1):68-76. PubMed ID: 17123268
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MERGE: A Multinational, Multicenter Observational Registry for Myeloproliferative Neoplasms in Asia, including Middle East, Turkey, and Algeria.
    Yassin MA; Taher A; Mathews V; Hou HA; Shamsi T; Tuğlular TF; Xiao Z; Kim SJ; Depei W; Li J; Rippin G; Sadek I; Siddiqui A; Wong RS
    Cancer Med; 2020 Jul; 9(13):4512-4526. PubMed ID: 32351024
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prospective, randomized, double-blinded, double-dummy and multicenter phase IV clinical study comparing the efficacy and safety of PG201 (Layla) and SKI306X in patients with osteoarthritis.
    Ha CW; Park YB; Min BW; Han SB; Lee JH; Won YY; Park YS
    J Ethnopharmacol; 2016 Apr; 181():1-7. PubMed ID: 26821189
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A structured summary of a study protocol for a multi-center, randomized controlled trial (RCT) of COVID-19 prevention with Kampo medicines (Integrative Management in Japan for Epidemic Disease by prophylactic study: IMJEDI P1 study).
    Namiki T; Takayama S; Arita R; Ishii T; Kainuma M; Makino T; Mimura M; Yoshino T; Nogami T; Arai M; Sato J; Tanaka K; Nakae H; Igari H; Ozawa Y; Shiko Y; Kawasaki Y; Nezu M; Ito T
    Trials; 2021 Jan; 22(1):23. PubMed ID: 33407828
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Online yoga in myeloproliferative neoplasm patients: results of a randomized pilot trial to inform future research.
    Huberty J; Eckert R; Dueck A; Kosiorek H; Larkey L; Gowin K; Mesa R
    BMC Complement Altern Med; 2019 Jun; 19(1):121. PubMed ID: 31174535
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pegylated interferon alpha - 2a is clinically effective and tolerable in myeloproliferative neoplasm patients treated off clinical trial.
    Gowin K; Jain T; Kosiorek H; Tibes R; Camoriano J; Palmer J; Mesa R
    Leuk Res; 2017 Mar; 54():73-77. PubMed ID: 28113109
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of Hochuekkito combined with pulmonary rehabilitation in patients with chronic obstructive pulmonary disease.
    Hamada H; Sekikawa K; Murakami I; Aimoto K; Kagawa K; Sumigawa T; Okusaki K; Dodo T; Awaya Y; Watanabe M; Kondo K; Ogawa T; Yamamoto H; Hattori N
    Exp Ther Med; 2018 Dec; 16(6):5236-5242. PubMed ID: 30542479
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.